Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement
Open Access
- 8 June 2018
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 41 (10) , 1494-1504
Abstract
Purpose There is paucity of data on patient-perceived outcomes of bleomycin sclerotherapy for low-flow vascular malformations. In this study, the long-term outcomes of bleomycin sclerotherapy were investigated in terms of quality of life (QoL) and patient-perceived changes in health. Materials and Methods A cohort of Dutch patients with vascular malformations treated with bleomycin sclerotherapy (June 2010-November 2015) completed a questionnaire evaluating disease symptoms, QoL (Short Form 36), patient-perceived change in health status (Global Rating of Change scales) and treatment satisfaction. QoL was assessed for the patient’s status before and after treatment and was analyzed relative to an age and sex-matched Dutch reference population. Predictive factors associated with QoL and patient-perceived improvement in overall health status were assessed using multivariable linear and logistic regression analyses, respectively. Results Seventy-seven patients, with a median follow-up of 22 months, were enrolled. About half of the respondents (49.3%) indicated that they perceived (any form of) improvement in their overall health status. Most often improved were the specific health aspects ‘pain’ (54.5%) and ‘overall severity of symptoms’ (57.1%). No factors were significantly predictive for patient-perceived improvement in health with respect to the vascular malformation. Impairment in work- or study-related activities prior to sclerotherapy was found to negatively impact physical QoL at follow-up (p = 0.03). Conclusion Approximately half of patients with low-flow vascular malformations indicate an improvement in overall health status following bleomycin sclerotherapy, particularly concerning pain and severity of symptoms. However, most patients only perceived little to moderate improvement to their health and desire further treatment.Keywords
This publication has 30 references indexed in Scilit:
- Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral EpicondylalgiaJAMA, 2013
- Low-flow vascular malformations of the head and neck: clinicopathology and image guided therapyJournal of NeuroInterventional Surgery, 2011
- Treatment of Low-flow Vascular Malformations by Ultrasound-guided Sclerotherapy with Polidocanol Foam: 24 Cases and Literature ReviewEuropean Journal of Vascular and Endovascular Surgery, 2011
- Percutaneous treatment of facial venous malformations: A matched comparison of alcohol and bleomycin sclerotherapyHead & Neck, 2011
- Sclerotherapy of lymphangiomas of the head and neckHead & Neck, 2010
- Baseline Quality of Life in patients with Klippel–Trenaunay syndromeJournal of Plastic, Reconstructive & Aesthetic Surgery, 2010
- Neurointerventional Management of Low-Flow Vascular Malformations of the Head and NeckNeuroimaging Clinics Of North America, 2009
- Quality of life in patients with vascular malformations of the lower extremityBritish Journal of Plastic Surgery, 2004
- Histological Investigation of Veins and Venous Malformations after Injection of Sclerosing AgentsAsian Journal of Oral and Maxillofacial Surgery, 2002
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992